A Potential Drug Target: LOC105374971 (Uncharacterized LOC105374971, Transcript Variant X2)

A Potential Drug Target: LOC105374971 (Uncharacterized LOC105374971, Transcript Variant X2)

LOC105374971 (Uncharacterized LOC105374971, transcript variant X2) is a gene that encodes a protein known as LOC105374971 (LOC105374971) in humans. LOC105374971 is a non-coding RNA molecule that has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and invasion. Furthermore, LOC105374971 has been associated with various diseases, including cancer and neurodegenerative disorders.

The search for potential drug targets is an ongoing process in the field of pharmacology, and LOC105374971 is an attractive candidate due to its unique structure and the various functions it is known to play. In this article, we will explore the potential of LOC105374971 as a drug target and highlight its potential as a biomarker for various diseases.

Potential Drug Target

The concept of drug targets is based on the idea that specific molecules, such as proteins or RNA molecules, are involved in the development and progression of many diseases. By blocking the function of these targets, drugs can be used to treat a wide range of conditions. LOC105374971 is a potential drug target due to its various functions and the evidence that it is involved in the development and progression of various diseases.

One of the key features that make LOC105374971 an attractive drug target is its expression in various tissues and cells. LOC105374971 is expressed in a variety of tissues, including brain, pancreas, and heart, and has been shown to play a critical role in cell adhesion, migration, and invasion. Additionally, LOC105374971 has been shown to be involved in the development and progression of various diseases, including cancer and neurodegenerative disorders.

In addition to its functions in disease progression, LOC105374971 is also a potential drug target due to its unique structure. LOC105374971 is a non-coding RNA molecule that has a unique 5'-end and 3'-end, as well as a unique stem-loop structure. This unique structure makes LOC105374971 an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its function.

Biomarker

LOC105374971 has also been shown to serve as a potential biomarker for various diseases. The expression of LOC105374971 is often reduced in various diseases, including cancer and neurodegenerative disorders. This reduced expression suggests that LOC105374971 may be a useful biomarker for these diseases.

In addition, LOC105374971 has been shown to play a critical role in cell adhesion and migration, which are important processes in the development and progression of many diseases. The expression of LOC105374971 has been shown to be associated with the migration of cancer cells and the development of neurodegenerative disorders.

Conclusion

LOC105374971 is a gene that has been associated with various diseases, including cancer and neurodegenerative disorders. Its unique structure and the various functions it is known to play make it an attractive candidate as a drug target or biomarker. Further research is needed to fully understand the role of LOC105374971 in disease progression and the development of new therapeutic approaches.

Protein Name: Uncharacterized LOC105374971

The "LOC105374971 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105374971 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105374974 | LOC105374976 | LOC105374985 | LOC105374989 | LOC105375005 | LOC105375010 | LOC105375016 | LOC105375019 | LOC105375020 | LOC105375021 | LOC105375024 | LOC105375032 | LOC105375033 | LOC105375039 | LOC105375043 | LOC105375047 | LOC105375056 | LOC105375063 | LOC105375065 | LOC105375069 | LOC105375070 | LOC105375088 | LOC105375091 | LOC105375104 | LOC105375120 | LOC105375122 | LOC105375139 | LOC105375161 | LOC105375170 | LOC105375172 | LOC105375175 | LOC105375179 | LOC105375186 | LOC105375194 | LOC105375195 | LOC105375199 | LOC105375204 | LOC105375207 | LOC105375218 | LOC105375230 | LOC105375235 | LOC105375236 | LOC105375237 | LOC105375242 | LOC105375264 | LOC105375275 | LOC105375284 | LOC105375291 | LOC105375310 | LOC105375337 | LOC105375340 | LOC105375341 | LOC105375347 | LOC105375361 | LOC105375379 | LOC105375381 | LOC105375404 | LOC105375410 | LOC105375423 | LOC105375428 | LOC105375429 | LOC105375434 | LOC105375440 | LOC105375443 | LOC105375448 | LOC105375451 | LOC105375452 | LOC105375490 | LOC105375492 | LOC105375494 | LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741